AI assistant
Sending…
Ascletis Pharma Inc. — Earnings Release 2005
Sep 23, 2005
50081_rns_2005-09-23_f874359c-8584-4e3f-bac8-06e390027a32.htm
Earnings Release
Open in viewerOpens in your device viewer
Listed Company Information
| Listed Company Information |
| WORLD HOUSEWARE<00713> - Results Announcement World Houseware (Holdings) Limited announced on 23/09/2005: (stock code: 00713 ) Year end date: 31/12/2005 Currency: HKD Auditors' Report: N/A Interim report reviewed by: Both Audit Committee and Auditors (Unaudited ) (Unaudited ) Last Current Corresponding Period Period from 01/01/2005 from 01/01/2004 to 30/06/2005 to 30/06/2004 Note ('000 ) ('000 ) Turnover : 394,244 378,042 Profit/(Loss) from Operations : 16,521 11,077 Finance cost : (5,130) (1,971) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : N/A N/A Profit/(Loss) after Tax & MI : 9,301 9,108 % Change over Last Period : +2.1 % EPS/(LPS)-Basic (in dollars) : 0.014 0.013 -Diluted (in dollars) : N/A 0.013 Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : 9,301 9,108 Interim Dividend : NIL 0.5 cent per Share (Specify if with other : N/A N/A options) B/C Dates for Interim Dividend : N/A Payable Date : N/A B/C Dates for (-) General Meeting : N/A Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: EARNINGS PER SHARE The calculation of the basic and diluted earnings per share is based on the following data: 1.1.2005 1.1.2004 to to 30.6.2005 30.6.2004 HK$'000 HK$'000 Earnings for the purpose of calculating basic and diluted earnings per share 9,301 9,108 _________ _________ Number of shares 1.1.2005 1.1.2004 to to 30.6.2005 30.6.2004 Number of shares for the purpose of calculating basic earnings per share 676,417,401 676,417,401 Potential dilutive shares issuable under share options - 497,252 ___________ ___________ Weighted average number of shares for the purpose of calculating diluted earnings per share 676,417,401 676,914,653 ___________ ___________ In the current period, no diluted earnings per share has been presented because the exercise price of the Company's options was higher than the average market price of the Company's shares and the options expired on 18 February 2005. |
More from Ascletis Pharma Inc.
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 7
Earnings Release
2026
Mar 31
Report Publication Announcement
2026
Mar 18
Regulatory Filings
2026
Mar 17